Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast (Q42493741)

1 November 2017

Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast (English)

1 reference

1 November 2017

1 reference

Mu-Min Shao

1

1 reference

1 November 2017

Fan Zhang

2

1 reference

1 November 2017

Gang Meng

3

1 reference

1 November 2017

Xing-Xing Wang

4

1 reference

1 November 2017

Hua Xu

5

1 reference

1 November 2017

Xue-Weng Yu

6

1 reference

1 November 2017

Liang-Yan Chen

7

1 reference

1 November 2017

Gary M Tse

8

1 reference

1 November 2017

1 August 2011

1 reference

1 November 2017

1 reference

1 November 2017

59

1 reference

1 November 2017

2

1 reference

1 November 2017

264-273

1 reference

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Identification of a basal-like subtype of breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03921.X

10.1111/J.1365-2559.2011.03921.X

21 January 2018

Identifiers

DOI

1 reference

release_fc2a2fbmibarrdplebo4boq644

1 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fc2a2fbmibarrdplebo4boq644

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference